CSE/XTRX (CSE/XTRX)

Canadian Securities Exchange: CSE/XTRX · CAD

CA$0.20

+0.00 (0.0%)· Recorded snapshot

Market cap	1.1M
Revenue (ttm)	16.9M
Net income (ttm)	-14.5M
EPS (ttm)	-CA$2.59
Shares out	5.6M
Volume	1,650
Beta	-0.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.9M
Net income (ttm): -14.5M
EPS (ttm): -CA$2.59
Market cap: 1.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-230.1

P25 -104.1P50 -30P75 6.7

ROIC-15.3

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/XTRX indicators

Market & fundamental data

Available fields

164

Groups with data

Currency

CAD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-09-04
Enterprise value	CAD 3.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2025-09-30
First seen	2026-05-10
Fiscal year end	December
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA00654D2095
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Last stock split date	2024-10-15
Last stock split type	Reverse
Market cap	CAD 1.1M
Price	CAD 0.20
Price currency	CAD
Sector	Healthcare
SIC code	1011
Stock price date	2026-05-12
Symbol	cse/XTRX
Website	https://adastraholdings.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1,294.21%
EV/Sales	0.23x
FCF / EV yield	-8.29%
FCF yield	-28.9%
Industry forward P/E	34.4x
P/S ratio	0.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-14.42%
EBITDA margin	-12.08%
Gross margin	32.66%
Operating margin	-14.42%
Pretax margin	-89.43%
Profit margin	-85.92%
ROA	-6.45%
ROA (5Y)	-10.05%
ROCE	261.52%
ROE	-230.09%
ROE (5Y)	-64.81%
ROIC	-15.34%
Tax / revenue	-3.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (Q)	-33.84%
FCF growth (QoQ)	44.05%
Gross profit growth	-32.24%
Gross profit growth (Q)	-50.84%
Gross profit growth 3Y	10.3%
Gross profit growth 5Y	101.56%
Net income growth years	0
OCF growth (Q)	-37.13%
OCF growth (QoQ)	45.9%
Revenue growth	-32.84%
Revenue growth (Q)	-33.22%
Revenue growth (QoQ)	63.1%
Revenue growth 3Y	14.85%
Revenue growth 5Y	68.15%
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -111,440
Depreciation and amortization	CAD 393,547
EBIT	CAD -2.4M
EBITDA	CAD -2M
EPS	CAD -2.59
FCF per share	CAD -0.06
Financing cash flow	CAD -204,491
Free cash flow	CAD -323,524
Gross profit	CAD 5.5M
Income taxes	CAD -593,000
Investing cash flow	CAD -714,539
Net borrowing	CAD -83,606
Net cash flow	CAD -1.1M
Net income	CAD -14.5M
Operating income	CAD -2.4M
Revenue	CAD 16.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.43
Book value per share	CAD -0.17
Interest coverage	-2.06
Long-term assets	CAD 9.5M
Long-term liabilities	CAD 17,614
Net cash (debt)	CAD -2.8M
Net cash / market cap	-248.77%
Piotroski F-Score	2
Property, plant and equipment	CAD 7.9M
Shareholders' equity	CAD -947,254
Tangible book value	CAD -950,836
Tangible book value per share	CAD -0.17
Total assets	CAD 16M
Total cash	CAD 786,599
Total debt	CAD 3.6M
Total liabilities	CAD 17M
WACC	20.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.72
Current assets	CAD 6.5M
Current liabilities	CAD 16.9M
Current ratio	0.38
Inventory turnover	2.63
Net working capital	CAD -7.7M
Quick ratio	0.15
Working capital	CAD -10.5M
Working capital turnover	-1.98

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.40
1D price change	0%
1Y price change	-40.3%
1Y return CAGR	-40.32%
1Y total return	-40.3%
20-day SMA	CAD 0.21
200-day SMA	CAD 0.64
3M price change	-4.76%
3M total return	-4.76%
3Y price change	-95.56%
3Y return CAGR	-64.57%
3Y total return	-95.56%
50-day SMA	CAD 0.22
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.80
52-week high date	2025-08-07
52-week low	CAD 0.15
52-week low date	2025-08-05
5Y price change	-97.92%
5Y return CAGR	-53.9%
5Y total return	-97.92%
6M price change	-24.53%
6M total return	-24.53%
All-time high	CAD 29.70
All-time high date	2020-08-18
All-time low	CAD 0.15
All-time low date	2025-08-05
Average true range (ATR)	CAD 0.02
Average volume	1.7K
Beta (1Y)	-0.34
Beta (2Y)	0.6
Beta (5Y)	-0.4
Change from 52-week high	-75%
Change from 52-week low	33.33%
Change from all-time high	-99.33%
Change from all-time low	33.33%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 330
High price	CAD 0.20
Low price	CAD 0.20
Monthly RSI	33.96
Open price	CAD 0.20
Previous close	CAD 0.20
Price vs 150-day SMA	-50.4%
Price vs 20-day SMA	-3.75%
Price vs 200-day SMA	-68.66%
Price vs 50-day SMA	-10.27%
Relative volume	0.95
RSI	45.66
Sharpe ratio	0.51
Sharpe ratio (3Y)	0.36
Sortino ratio	0.88
Sortino ratio (3Y)	0.65
Volume	1.7K
Weekly RSI	37.83
YTD price change	-14.89%
YTD total return	-14.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.5M
Shares change (QoQ)	0%
Shares held by insiders	1.27%
Shares outstanding	5.6M

Deeper analysis on CSE/XTRX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/XTRX report

Is a complete CSE/XTRX research report available?

No complete published report is available for cse/XTRX (CSE/XTRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/XTRX (CSE/XTRX)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/XTRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/XTRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on CSE/XTRX

Frequently asked questions